Core Laboratories (CLB) Net Margin (2022 - 2026)

Core Laboratories' Net Margin history runs 5 years deep, the most recent figure standing at 0.62% for Q1 2026.

• On a quarterly basis, Net Margin fell 67.0% year-over-year to 0.62% in Q1 2026; TTM through Mar 2026 was 5.63%, a 80.0% decrease from a year earlier, with the FY2025 full-year figure at 5.77%, down 122.0% from the prior year.
• Net Margin retreated to 0.62% in Q1 2026 per CLB's latest filing, from 3.71% in the prior quarter.
• Across five years, Net Margin topped out at 17.93% in Q2 2023 and bottomed at 6.7% in Q4 2023.
• The 5-year median for Net Margin is 6.56% (2024), against an average of 5.63%.
• Across the five-year window, Net Margin sank 1420 bps in 2023 and jumped 1597 bps in 2024, its largest moves.
• Year by year, Net Margin stood at 7.5% in 2022, then slumped by 189 bps to 6.7% in 2023, then surged by 239 bps to 9.28% in 2024, then tumbled by 60 bps to 3.71% in 2025, then tumbled by 117 bps to 0.62% in 2026.
• Per Business Quant, the three latest CLB Net Margin figures stand at 0.62% (Q1 2026), 3.71% (Q4 2025), and 10.76% (Q3 2025).